DNA vaccine: Partner Merck started a Phase I escalating-dose trial

Vical Inc. (VICL), San Diego, Calif. Product: DNA vaccine Use: Prevent influenza Status: Partner Merck started a Phase I escalating-dose trial to evaluate immune responses in human volunteers. Dosage...